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Abstract
Gene expression of DNA viruses requires nuclear import of the viral genome. Human Adenoviruses (Ads), like most DNA
viruses, encode factors within early transcription units promoting their own gene expression and counteracting cellular
antiviral defense mechanisms. The cellular transcriptional repressor Daxx prevents viral gene expression through the
assembly of repressive chromatin remodeling complexes targeting incoming viral genomes. However, it has remained
unclear how initial transcriptional activation of the adenoviral genome is achieved. Here we show that Daxx mediated
repression of the immediate early Ad E1A promoter is efficiently counteracted by the capsid protein VI. This requires a
conserved PPxY motif in protein VI. Capsid proteins from other DNA viruses were also shown to activate the Ad E1A
promoter independent of Ad gene expression and support virus replication. Our results show how Ad entry is connected to
transcriptional activation of their genome in the nucleus. Our data further suggest a common principle for genome
activation of DNA viruses by counteracting Daxx related repressive mechanisms through virion proteins.
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Introduction
DNA viruses require the transport of their genome into the nucleus
to initiate replication. Cells perceive the introduction of foreign
nucleic acids or unscheduled replication as danger signals and
activate a DNA damage response that leads to cell cycle arrest and/
or apoptosis. To ensure proper replication, DNA viruses express
‘early’ viral genes to degrade or displace key regulators of cellular
antiviral machinery. In return, cells repress incoming viral genomes
through a network of transcriptional repressors and activators that
normally control cellular homeostasis [reviewed in 1,2].
The nuclear domains thought to be responsible for repressing
viral genomes are ND10 or promyelocytic nuclear bodies [PML-
NBs; reviewed in 3,4] named after the scaffolding PML protein.
PML-NBs are interferon inducible, dot-like nuclear structures
associated with proteins with transcriptional repressive functions.
These include HP-1, Sp100, ATRX and Daxx [summarized in
4,5]. Daxx (death domain associated protein) was first described as
a modulator of Fas-induced apoptotic signaling [6]. When
chromatin-bound, Daxx inhibits basal gene expression from
various promoters by binding to transcription factors (e.g. p53/
p73, NF-kappaB, E2F1, Pax3, Smad4 or ETS1), ATRX, histone
deacetylases and core histones to form a repressive chromatin
environment [7–13]. In contrast, Daxx localization to PML-NBs
reduces its repressive capacity and facilitates apoptosis through
p53 family members [5,7,14].
PML-NBs are found in close proximity to replication centers of
DNA viruses (e.g. adenoviruses (Ads), herpes simplex virus (HSV-
1), human cytomegalovirus (HCMV) and human papillomavirus
[HPV; 15,16–18]. Gene expression from these viruses is repressed
via the PML-NBs, suggesting a role in antiviral defense [19–22].
To counteract genome repression, viral genome activation
involves PML-NB disruption or degradation of Daxx, Sp100 and/
or PML via different mechanisms. HCMV gene expression is
initiated by proteasomal degradation of Daxx via tegument
protein pp71 of the incoming particle [23]. Early HSV-1 gene
expression requires PML degradation, mediated by the virus
encoded ubiquitin ligase ICP0. Furthermore, in order to activate
viral gene expression, transcriptional repression by Daxx and
ATRX needs to be relieved [3,24,25]. HPV early gene expression
is supported by reorganization of PML-NBs through the minor
capsid protein L2 [26].
At the beginning of infection, Ads express the immediate early
protein E1A from the E1A promoter. E1A binds and displaces
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the transcriptional repressor Rb from E2F transcription factors.
This results in the auto-stimulation of E1A expression and the
activation of the downstream viral expression units E1B, E2, E3
and E4 as well as promoting cellular gene expression. The early
E1B-55K protein forms a SCF-like E3-ubiquitin ligase complex
with the viral E4orf6 and several cellular factors. This complex
degrades factors (for example, factors of the DNA damage
response) to ensure progression of the replication cycle [summa-
rized in 1,2,27]. E1B-55K protein complex also targets Daxx for
proteasomal degradation counteracting its repressive effect [21].
In contrast to HSV-1, PML is not degraded by Ads but
relocalized into track-like structures through the E4orf3 protein
[28,29].
Despite the well-characterized mechanism of E1A dependent
transactivation of early Ad genes, it is unclear how the E1A
transcription is efficiently initiated before other viral genes are
expressed. The genome enters the cell as a transcriptionally
inactive nucleoprotein complex, which is highly condensed by
the histone-like viral protein VII inside the capsid shell. Partial
disassembly of the endocytosed capsid releases the endosomo-
lytic internal capsid protein VI, permitting endosomal mem-
brane penetration [30,31] and transport towards the nucleus.
After import through the nuclear pore complex, Ad genomes
associate with PML-NBs and replication centers are established
[30,31,reviewed in 32,33–35]. Endosomal escape and subse-
quent transport are facilitated by Nedd4 ubiquitin ligases, which
are recruited through a conserved PPxY motif in protein VI.
Ads with mutated PPxY motif do not bind Nedd4 ligases and
have reduced infectivity, showing the importance of this
interaction for the onset of gene expression from the viral
genome [36].
Here we report that Ad capsid proteins and cytoplasmic entry
steps are linked to initiation of the adenoviral E1A expression by
counteracting Daxx mediated transcriptional repression. Using the
Ad system, we further show that capsid proteins from several other
DNA viruses share and complement this function. This suggests a
conserved mechanism among DNA viruses and provides insights
into the very early virus-host interactions required to establish an
optimal cellular environment for productive infection.
Results
Ad with PPxY-mutated protein VI exhibits reduced
replication fitness
The capsid protein VI participates in two crucial steps in the
nuclear delivery of the Ad genome. Firstly, protein VI is required for
lysis of endosomal membranes. Secondly, it is needed for efficient
post-endosomolytic transport, mediated by the cellular ubiquitin
ligase Nedd4 that binds to a conserved PPxY motif in protein VI.
Mutating the PPxYmotif interferes with capsid transport toward the
nucleus and efficient viral gene expression [30,36].
To investigate the role of protein VI during post-endosomolytic
steps required for the onset of viral replication, we constructed
replication competent Ads containing the E1 region with either
wildtype (wt) protein VI (HH-Ad5-VI-wt, depicted in the Figure
S1) or mutant ‘‘M1’’ protein VI in which the PPSY motif was
mutated to PGAA that abolished Nedd4 interaction [HH-Ad5-
M1; Fig. S1; 36]. Following infection of U2OS cells, we observed
that M1 virus replication was attenuated compared to wt
(Figure 1A and S1B). This is in agreement with our previous
observations showing reduced infectivity of an E1-deleted M1 Ad
vector compared to the corresponding E1-deleted wt Ad vector
[36]. To distinguish between capsid transport and possible more
downstream effects, we infected cells with different amounts of
replication competent wt and M1 viruses. Then, we determined
the genome copy numbers in nuclear and cytoplasmic fractions by
qPCR and the efficiency of the initiation of virus replication by
quantification of E2A stained replication centers (detailed in
Figure S2). Compared to wt, fewer M1 virus genomes accumu-
lated in the nucleus associated fraction, independent of the amount
of input virus. In contrast, initiation of virus replication for M1
genomes was reduced for low, but not at high physical particle per
cell ratios (Figure S2) suggesting defects downstream of virus
nuclear transport.
Therefore, the expression of the early viral proteins E1A, E1B-
55K and E2A in wt and M1 infected cells was analyzed by western
blot, starting 8 h post infection (p.i.) and throughout the whole
replication cycle (Figure 1B, left panel). We observed that
expression of E1A in M1 virus infected cells was reduced
compared to wt (Figure 1B, right panel) and accordingly, all
other gene products were expressed with a delayed kinetic. This
observation can be explained by the initial lower levels of E1A
expression, because E1A is required for full activity of Ad
downstream promoters [37]. Thus, we next investigated if the
reduced E1A protein expression in M1-infected cells was due to
reduced transcriptional activation of the E1A promoter following
infection. We isolated and quantified newly synthesized E1A
mRNA from cells infected with wt and M1 virus starting as early
as 1–2 h p.i. (Figure 1C). The results confirmed that, at 1–4 h p.i.,
M1-infected cells showed reduced levels of newly synthesized E1A
mRNA compared to wt-infected cells. Interestingly this reduction
was gradually compensated throughout the first hours of infection
(Figure 1C, compare 1–2 h, 3–4 h and 5–6 h) suggesting that low
levels of initially made E1A were sufficient to compensate for the
M1-defect in E1A transcription.
The high particle per cell ratio requirement for transcriptional
activation and the reduced levels of E1A mRNA and E1A protein
expression for the M1 virus indicated that the PPxY motif in
protein VI not only affects transport towards the nucleus, but also
early viral gene expression, presumably through separate mech-
anisms.
Author Summary
To initiate infection, DNA viruses deliver their genome to
the nucleus and express viral genes required for genome
replication. Efficient transport is achieved by packing the
viral genome as a condensed, transcriptionally inactive
nucleo-protein complex. However, for most DNA viruses,
including Adenoviruses (Ads), it remains unclear how the
viral genome is decondensed and how transcription is
initiated inside the nucleus. Cells control unwanted gene
expression by chromatin modification mediated through
transcriptionally repressive complexes. A key factor in
repressive complex assemblies is the transcriptional
repressor Daxx. The Ad structural capsid protein VI is
required for endosomal escape and nuclear transport. Here
we show that protein VI also activates the Ad E1A
promoter to initiate Ad gene expression. This is achieved
through the removal of Daxx repression from the E1A
promoter, which requires a conserved ubiquitin ligase
interacting motif (PPxY-motif) in protein VI. We further
show that capsid proteins from other unrelated DNA
viruses also activate the Ad E1A promoter and support Ad
replication by counteracting Daxx repression, functionally
replacing protein VI. Our data suggest that reversal of Daxx
repression by virion proteins is a widespread mechanism
among DNA viruses that is not restricted to a single virus
family.
Adenoviral Genome Activation
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Figure 1. Viruses with mutated PPxY motif in protein VI (M1) have altered gene expression. (A) U2OS cells were infected with replication
competent HH-Ad5-VI-wt or HH-Ad5-VI-M1 with a multiplicity of infection (MOI) of 50 FFU/cell (see Figure S1). Viral particles were harvested at 24, 48 and
72 h p.i. and virus yield was determined by quantitative E2A stain. The results represent the average from three independent experiments. (B) U2OS cells
were infected with HH-Ad5-VI-wt or HH-Ad5-VI-M1 at a MOI of 50 FFU/cell and whole-cell extracts were prepared after indicated time-points and
subjected to immunoblotting (IB). Corresponding proteins are indicated to the right. MOI dependent replication differences are shown in Figure S2. (C)
Cells were infected as in A and newly synthesized RNAs were labelled for the time p.i. as indicated on the x-axis and described in the materials and
methods section. Extracted RNAs were reverse transcribed and quantified using qPCR using exon-spanning E1A specific primers and normalized against
GAPDH mRNA levels. E1A mRNA levels in wt-infected cells were arbitrarily set to 100%. Data are derived from three independent experiments.
doi:10.1371/journal.ppat.1002549.g001
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Capsid protein VI of incoming Ads is targeted to
PML-NBs
We previously showed that protein VI contains nucleo-
cytoplasmic transport signals [38]. To test if protein VI could
play a direct role in the initial activation of the viral genome, we
first analyzed whether protein VI from incoming Ad capsids is
imported into the nucleus. Using nucleo-cytoplasmic fractionation,
we observed rapid protein VI accumulation in the nuclear fraction
after infection (Figure 2A).
Fractionation does not discriminate between nuclear (inside) or
nucleus-associated (outside) accumulation of protein VI (e.g.
capsid-associated at the microtubule organizing center). Thus,
we investigated the subcellular localization of protein VI derived
from entering viral particles by confocal microscopy in synchro-
nous infected cells. Within one hour, we observed protein VI
specific signals in dot-like structures inside the nucleus for wt- and
the M1-virus. Using antibodies (Ab) against PML, we showed
some protein VI associated with PML-NBs (Figure 2B).
We confirmed the association of some protein VI with PML-
NBs in a virus free system by transfecting protein VI-mRFP alone
or together with EGFP-PML expressing plasmids into U2OS cells.
Transfected proteins were detected via the mRFP and EGFP
signal or with specific Ab for endogenous PML (‘‘endogenous’’
highlighted throughout the text and in figures by the suffix ‘‘e’’,
e.g. ePML). The results show that protein VI was able to
independently associate with PML-NBs (Figure 2C). Using a serie
of protein VI mutants, we mapped the region of protein VI
required for PML-NB association (Figure S3). This analysis
revealed that the N-terminal amphipathic helix was required for
efficient PML-NB targeting, because a mutant (VI-delta54) deleted
of the amphipathic helix showed a diffuse nuclear distribution
(Figure S3). We repeatedly observed the clustering of PML in
transfected cells, suggesting PML-NB structure modulation
resulting from protein VI expression. In summary, these data
showed that some protein VI from incoming Ad particles is
targeted into the nucleus, where some of it consistently localizes
adjacent to PML-NBs, suggesting an involvement in additional
intranuclear steps.
Protein VI interacts with and counteracts the PML-NB
associated factor Daxx
It was recently reported by some of the co-authors of this work
that the transient PML-NBs resident factor Daxx suppressed Ad
replication and was degraded late in the infection cycle [21]. The
observation that some protein VI was associated with PML-NBs
prompted us to investigate whether PML itself, or PML-NB-
associated factors such as Daxx, interact with protein VI. These
interactions could provide an explanation for the reduced
transcription of the E1A promoter observed for the M1 virus.
Cells were infected with HH-Ad5-VI-wt or -VI-M1 and harvested
after 24 h. Lysates were subjected to immunoprecipitation (IP)
using PML or Daxx specific Ab and analyzed by western blot
(Figure 3A). The data showed that protein VI could be
precipitated from both wt and M1 infected cells using either
PML or Daxx specific Ab. In contrast to virus infected cells, we did
not detect co-precipitated protein VI following cotransfection and
IP with different PML isoforms, suggesting an indirect association
of PML and protein VI, presumably bridged by other viral or
infection induced factors (Figure 3B). In contrast, co-IP of protein
VI with Daxx also occurred after isolated transfection of protein
VI-wt as well as protein VI-M1 suggesting that the interaction is
independent of other viral factors (Figure 3C). We next asked
whether Daxx interaction with protein VI could explain the
reduced replication of HH-Ad5-VI-M1. For these assays, we used
the hepatoma derived cell line HepaRG, because of its close
resemblance to primary cells [39], and HepaRG cells depleted of
Daxx (HAD, Daxx was depleted with shRNA expressing lentiviral
vectors [20]). We infected Daxx-depleted HAD and HepaRG
parental cells with HH-Ad5-VI-wt and HH-Ad5-VI-M1 and
determined virus yields and gene expression at 12, 24 and 72 h p.i.
(Figure 3). The M1 virus was more strongly attenuated in
HepaRG cells than in U2OS cells (compare to Figure 1), while
Daxx depletion strongly enhanced virus production for both
viruses and nearly restored the M1 virus yields to wt levels
(Figure 3D). This improvement of Ad permissivity was confirmed
by an increase of expression of all analyzed viral genes, including
gene products from the E1A and E1B promoters (Figure 3E).
The data showed that Daxx depletion was sufficient to increase
Ad gene expression for both viruses, emphasizing the role of Daxx
in viral genome repression. In addition, wt but not M1 mutant
protein VI could counteract Daxx mediated inhibition indicating
that the PPxY motif of protein VI plays a significant role in
initiating viral gene expression.
PPxY motif is essential to reverse Daxx-mediated
repression of Ad E1 promoters
Next, we asked whether the Ad immediate early E1A and early
E1B promoters are targeted by Daxx mediated repression and if
this is the case whether it can be reversed by protein VI. To this
end, we constructed luciferase expression vectors controlled by the
Ad E1A and E1B promoters and measured luciferase expression in
protein VI-wt or protein VI-M1 transfected H1299 cells
(Figure 4A). Unlike VI-M1, VI-wt was able to stimulate expression
from the E1A promoter ,2.5-fold and ,1.5-fold from the E1B
promoter (Figure 4A). To show direct association of protein VI
with E1 promoters, we performed chromatin immunoprecipitation
assays (ChIP) at 48 h p.i from M1- or wt virus infected cells, using
protein VI specific serum and Ad promoter-specific primers
(Figure 4B). The results show that the VI-wt protein was much
more strongly associated with the E1A and E1B promoter in
infected cells than the VI-M1 protein, which is also reflected in
their relative activation ability (Figure 4B, compare with 4A). To
analyze whether protein VI associated activation of Ad early
promoters is involved in Daxx de-repression, we cotransfected the
E1B promoter driven luciferase expression vector in absence or
presence of Daxx with protein VI-wt or VI-M1 expression vectors.
Figure 2. Nuclear accumulation of protein VI at PML-NBs during entry. (A) U2OS cells were infected with HH-Ad5-VI-wt at a MOI of 1000
FFU/cell and fractionated at 20 min intervals and subjected to IB using serum against protein VI, polyclonal Ab (pAb) against the splicing factor SAF-A
(nuclear fraction) and monoclonal Ab (MAb) against b-actin (cytoplasmic fraction) as indicated to the right. (B) U2OS cells were synchronously
infected with HH-Ad5-VI-wt (top row) or HH-Ad5-VI-M1 (bottom row) and fixed after 1 h. Endogenous PML (first column) and virus, derived protein VI
(second column), were detected with specific Ab. In the overlay PML is shown in green and protein VI in red (third column). A detailed magnification
of the white rectangle is given in the fourth column. (C) U2OS cells were transfected with mRFP-tagged protein VI and GFP-tagged PML expression
vectors (top row) or mRFP-tagged protein VI followed by Ab stain of ePML (bottom row). Intracellular localization of PML (first column), protein VI
(second column) or an overlay of both is shown (colors as above, third column). Colocalization is indicated by arrows (fourth column) and occurred in
all transfected cells. A mapping of the interaction between VI and PML is shown in Figure S3.
doi:10.1371/journal.ppat.1002549.g002
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Protein VI-wt, but not VI-M1, alleviated Daxx repression
implying a role for the PPxY motif (Figure 4C). Although there
was less binding to protein VI compared to the E1A promoter, we
observed a strong effect on the activation of luciferase expression
in that experiment. We also tested if protein VI (wt or M1)
stimulates other Ad promoters using luciferase expression vectors
for all viral promoters. The data showed that protein VI-wt was
able to stimulate most of the Ad promoters in absence of other
viral factors to various degrees (Figure S4). The strongest induction
was observed for the immediate early E1A and E2A early
promoter, which is in agreement with the weak E2A expression
observed in HepaRG cells in M1-virus infected cells and the
restoration of E2A expression following Daxx depletion (see
Figure 3E). In contrast, E3 and E4 promoter activation was weak
with no clear difference between wt and M1. In the context of an
ongoing virus infection, the transcriptional activation of both
promoter groups (E1/E2 vs. E3/E4) was shown to be regulated by
E1A but via different mechanisms [40,41]. Thus, our data showed
that protein VI might also play a minor role in the transcriptional
activation of the E1/E2 promoter group.
Altogether, the promoter analysis suggests that protein VI plays
a so far not recognized role in the Ad gene expression program.
Daxx is translocated into the cytoplasm by protein VI
We next asked how the PPxY motif of protein VI contributes to
Daxx de-repression. In previous work, we showed that this motif
mediates protein VI interaction with cytoplasmic Nedd4 ubiquitin
ligases [36]. Overexpression of protein VI and/or Nedd4 did not
result in a change of steady-state Daxx levels (data not shown)
suggesting that de-repression was not achieved through Daxx
degradation as e.g. as shown for HCMV. However, when we
tested if protein VI targets Nedd4 ligases to PML-NBs our analysis
showed that protein VI-wt, but not VI-M1 targets Nedd4 ligases
towards PML-NBs. This targeting required the PPxY motif and
the amphipathic helix, but was independent of catalytical Nedd4
activity suggesting that Nedd4 ligases could be involved in other
steps of counteracting Daxx repression by protein VI (Figure S5).
As a next step, we therefore analyzed whether the subcellular
distribution of Daxx was altered in response to protein VI and
Nedd4 expression. In non-transfected cells, endogenous Daxx
(eDaxx) is nuclear in steady state with some Daxx localizing to dot-
like intranuclear structures resembling PML-NBs (Figure 5a).
When we transfected expression vectors for protein VI-wt or VI-
M1 into U2OS cells, nuclear localization of eDaxx was lost and
eDaxx colocalized with transfected protein VI in the cytoplasm
(Figure 5b and e). In contrast, following transfection of expression
vectors for protein VI-wt and Nedd4 ligases, eDaxx remained
nuclear and instead protein VI-wt colocalized with Nedd4 ligases
in the cytoplasm (Figure 5c). When we transfected expression
vectors for Nedd4 ligases and protein VI-M1, protein VI retained
the capacity of translocating eDaxx to the cytoplasm (Figure 5f).
These data suggested that binding of Nedd4 to the PPxY motif of
protein VI efficiently competed with protein VI-dependent
cytoplasmic translocation and/or cytoplasmic retention of Daxx.
This effect did not require Nedd4 ubiquitin ligase activity
(Figure 5d). Thus, our results suggested that the PPxY motif
present in wt protein VI could influence the dynamic nucleo-
cytoplasmic distribution of Daxx.
Protein VI displaces Daxx from PML-NB
To continue our analysis in a more physiological setting, we
analyzed the subcellular localization of Daxx during Ad entry
(Figure 6). In uninfected control cells, Daxx localized to the
nucleoplasm and into PML-NBs. Within the first hour of infection,
Daxx remained largely nuclear in wt- as well as M1-virus infected
cells. Occasional cytoplasmic Daxx was never virus particle-
associated. In contrast to non-infected cells, we observed a trend
towards intranuclear displacement of Daxx from PML-NBs and
PML clustering following infection (Figure 6A, red arrows), which
could be clearly distinguished from Daxx spots in uninfected cells.
This suggests that incoming viruses displace Daxx from PML-NBs
by a mechanism independent of the PPxY motif of protein VI and
prior to initial viral gene expression. Because we noticed
occasionally large PML-NBs in infected cells, we next quantified
the number of PML-NBs in wt- and M1-infected cells compared to
non-infected cells. The results showed that on average, infected
cells had less PML-NBs than non-infected cells, supporting our
observation that PML-NBs were clustering (Figure 6B) and that
the effects where PPxY motif independent. To show that the Daxx
displacement from PML-NBs in the very early infection phase was
caused by protein VI, we analyzed Daxx dissociation from PML-
NB also in VI-wt and VI-M1 transfected cells (Figure S6).
Compared to non-transfected cells, expression of protein VI-wt or
VI-M1 led to translocation and cytoplasmic colocalization of Daxx
(as seen in Figure 5). In addition, in several cells, Daxx was
partially or completely displaced from PML-NBs and PML formed
large nuclear clusters similar to those observed in infected cells
(Figure S6, red arrows). We also transfected cells with expression
vectors for HCMV pp71 tegument protein, known to interact with
Daxx [42]. Unlike for protein VI, in pp71 transfected cells, Daxx
remained nuclear and localized to some degree with PML into
pp71 induced, ring-like structures also partially displacing Daxx
from PML-NBs (Figure S6).
To directly follow Daxx displacement from PML-NBs and from
the nucleus, we used microinjection of recombinant protein VI
(Figure 7 and Videos S1, S2, S3). We transfected U2OS cells with
Daxx-mCherry and PML-GFP expression constructs, and injected
the cytoplasm with either control buffer, recombinant VI-wt or
Figure 3. Protein VI interaction with PML and the PML-NB associated factor Daxx and rescue of HH-Ad5-VI-M1 replication by Daxx
depletion. (A) H1299 cells were infected with HH-Ad5-VI-wt or HH-Ad5-VI-M1 at a MOI of 50 FFU/cell. Total-cell extracts were prepared 36 h p.i. and
subjected to IB using specific Ab as indicated. Right panel : co-immunoprecipitation (IP) of protein VI was performed with Daxx-/PML-specific Ab
followed by IB and detection of co-precipitated protein VI. (B) H1299 cells were transfected with mRFP tagged VI-wt and different constructs
encoding for N-terminal flag-tagged human PML-isoforms I-VI and harvested after 24 h. Total-cell extracts were subjected to IB using Ab against flag-
tag, RFP, VI or b-actin (top panel). IP of PML-isoforms was done using flag-specific MAbs M2. Detection of co-precipitated protein VI was done with
serum against pVI or MAb against RFP. Immunoprecipitated PML proteins were detected with flag-specific MAb M2 (bottom panel). (C) H1299 cells
were transfected with HA-tagged Daxx, RFP-tagged VI-wt and VI-M1 proteins. Total-cell extracts were prepared 24 h p.i. and analyzed by IB using
specific Ab shown to the right. IP of protein VI was done with serum against pVI. Note that the size difference between VI-wt and VI-M1 results from
fusion to mRFP (wt) or mCherry (M1). (D) HepaRG parental and HAD cells were infected with HH-Ad5-VI-wt or HH-Ad5-VI-M1 at a MOI of 50 FFU/cell.
Viral particles were harvested at 24, 48 and 72 h p.i. and virus yield was determined by quantitative E2A stain. The results represent the average from
three independent experiments (+/2 STD). (E) HepaRG parental (top) and HAD (bottom) cells were infected with HH-Ad5-VI-wt or HH-Ad5-VI-M1 at a
MOI of 50 FFU/cell and whole-cell extracts were prepared after indicated time-points. Proteins were subjected to IB using Ab specific for viral proteins
as indicated on the right.
doi:10.1371/journal.ppat.1002549.g003
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with recombinant VI-M1 (Figure 7B) and followed the distribution
of Daxx-mCherry using live-cell imaging (Figure 7A). Daxx-
mCherry was exclusively localized to the nucleoplasm and PML-
NBs, while PML-GFP showed an intranuclear dot-like distribution
with some cytoplasmic aggregates at higher levels of expression.
Cytoplasmic injection of protein VI-wt or VI-M1 led to
displacement of Daxx from PML-NBs and cytoplasmic accumu-
lation of Daxx within minutes of injection (Figure 7A, first and
second row compared to buffer controls in the last row). We
quantified the cytoplasmic accumulation of Daxx by measuring
nuclear Daxx fluorescence loss following microinjection. This
quantification revealed that Daxx nuclear export occurred more
rapidly post injection of protein VI-wt than VI-M1, suggesting that
the PPxY motif accelerated the process of Daxx displacement
(Figure 7C). Notably, Daxx displacement was paralleled by a
strong increase in intranuclear mobility of PML-GFP and by
fusion events between individual bodies (Videos S1 and S2), thus
providing evidence that the large clustered PML-NBs, observed in
fixed cells, result from the mobilization of Daxx out of the bodies.
We also microinjected recombinant protein VI (VI-delta54),
lacking the amphipathic helix required for PML-NB targeting of
protein VI, to see whether PML-NBs association is required for
Daxx displacement. In contrast to protein VI-wt and VI-M1,
injection of VI-delta54 only transiently displaced Daxx from PML-
NBs and did not result in Daxx cytoplasmic translocation
(Figure 7A third row and Video S3). The Daxx residence time
in PML-NBs is ,2 seconds [43]. Therefore our observation could
be explained by competitive binding of VI-delta54 to Daxx, which
could transiently prevent Daxx from association with PML-NBs.
In summary, these data strongly suggested that protein VI from
incoming adenoviral capsids can displace Daxx from PML-NBs,
which in turn affects the PML-NB architecture leading to the
accumulation of PML in large intranuclear clusters. Our analysis
further indicate that association of protein VI with PML-NBs
through the amphipathic helix is not strictly required for Daxx
displacement from PML-NBs and that the PML-NB rearrange-
ments take place prior to or are concomitant with the initiation of
adenoviral transcription.
Virion constituents from other DNA viruses can replace
protein VI to promote E1A expression
Our data showed that protein VI activates the Ad E1 promoters
by reversing Daxx repression, presumably until newly synthesized
E1A can secure the Ad gene expression program. In this case,
virion proteins derived from other DNA viruses known to abrogate
Daxx repression should be able to substitute this function. To test
this possibility, we tested whether the expression from the E1A
promoter can be activated by the HCMV pp71 tegument protein
or by the HPV L2 minor capsid protein, which both target Daxx
[26,44]. Similar to protein VI-wt, pp71 and L2 were able to
stimulate the Ad E1A promoter (Figure 8A). Furthermore, we
observed that like protein VI-wt, pp71 and L2 could also drive
efficient E1A and E1B expression from a subviral construct,
preserving the virus context encoding the E1A and E1B
transcription units (Figure 8B, lane 3, 6 and 7). These results
show that non-adenoviral virion proteins are also capable of
inducing immediate early adenoviral gene expression in the
absence of any further Ad protein. This induction of gene
expression was through mediating transcriptional activation, as
shown by elevated E1A and E1B mRNA levels (Figure 8C).
Similarly, this result confirmed that elevated E1A mRNA and
protein expression levels driven by protein VI require the PPxY
motif, thus directly linking entry and early viral gene expression
(Figure 8B, lanes 1–4). To extend the analysis for other regions of
protein VI, we used the expression construct encoding protein VI-
delta54, lacking the amphipathic helix, which is required to target
protein VI to PML-NBs (Figure S3d). The results showed that like
protein VI-M1, the construct expressing VI-delta54 only margin-
ally stimulated the E1A promoter (compare wt-, M1 and delta54
in Figure 8A and C). In contrast, the expression of protein VI-
delta54 resulted in somewhat elevated protein expression levels
compared to VI-M1 suggesting that it might promote E1A
expression on a post-transcriptional level. This could result from
the diffuse localization of VI-delta54 in the nucleoplasm of
transfected cells (compare with Figure S3). In summary, this
analysis showed that efficient transcriptional activation of the E1A
promoter requires the amphipathic helix in addition to the PPxY
motif.
If the HCMV tegument protein pp71, that is known to remove
Daxx repression from the immediate early HCMV promoter [45],
activates the Ad E1A promoter, it was conceivable to speculate
that protein VI would also be able to stimulate the immediate early
HCMV promoter. To test this hypothesis, we constructed viral
vectors encoding wt- or M1-mutated protein VI where the E1
region was replaced by a HCMV promoter controlled GFP (wt) or
mCherry (M1) expression unit. We transduced U2OS cells with
M1-vectors and increasing amounts of wt virus and quantified
gene expression using fluorescent activated cell sorting. The results
showed partial restoration of the (HCMV promoter controlled)
marker gene expression from VI-M1 vector transduced cells only
in cells that were co-transduced with the M1-vector and the wt-
vector (Figure S7). This analysis suggested that protein VI
stimulated the HCMV promoter in trans, like pp71 could stimulate
the Ad E1A promoter in trans (Figure S7). Taken together the
effects that protein VI has on the E1A promoter are comparable,
and moreover compatible and interchangeable, with the HCMV
or papillomavirus virion derived immediate early enhancing
activities.
Transactivating virion components from other DNA
viruses promote Ad replication
Because protein VI, pp71 and L2 can stimulate Ad E1A
expression independently, we next asked if they could compensate
for the lack of functional PPxY motif in the replication competent
HH-Ad5-VI-M1 virus. We transfected cells with expression
vectors for protein VI-wt, VI-M1 and VI-delta54 (Figure 9A)
and HCMV tegument protein pp71 and HPV small capsid protein
L2 (Figure 9B) followed by infection with HH-Ad5-VI-wt or HH-
Figure 4. Protein VI mediates Ad transcriptional activation. (A) H1299 cells were transfected with luciferase reporter plasmids under E1A
promoter- (left panel), E1B promoter- (right panel) or promoterless control and effector plasmids expressing VI-wt or VI-M1. Forty eight hours after
transfection, samples were lysed, absolute luciferase activity was measured and activity of the E1 promoter alone was normalized to 100%. Mean and
STD are from three independent experiments. Effects on additional viral promoters are shown in Figure S4. (B) H1299 cells were infected with HH-
Ad5-VI-wt or HH-Ad5-VI-M1 at a MOI of 50 FFU/cell. Forty eight hours p.i., cells were fixed with formaldehyde and ChIP analysis was performed as
described in materials and methods. The average Ct-value was determined from triplicate reactions and normalized with standard curves for each
primer pair. The y-axis indicates the percentage of immunoprecipitated signal from the input ( = 100%). (C) HAD cells were transfected with E1B
promoter constructs and effector plasmids encoding for Daxx, VI-wt, VI-M1. Forty eight hours after transfection, samples were lysed and analyzed as
in (A). Mean and STD are from three independent experiments.
doi:10.1371/journal.ppat.1002549.g004
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Ad5-VI-M1 virus. The analysis showed that protein VI-wt was
able to fully compensate for the M1 mutation in the virus and
restored progeny virus production to wt levels, while protein VI-
M1 was not able to rescue virus production and VI-delta54
resulted only in partial rescue (Figure 9A). Amazingly, HCMV
pp71 and HPV L2 were also fully capable of complementing the
M1 mutant virus and restored progeny virus production to wt
levels (Figure 9B). Lastly, we wanted to know if the adenoviral
protein VI capsid protein was also able to stimulate an immediate
early promoter in the context of a non-related virus infection. We
transfected U2OS cells with protein VI-wt and VI-M1 or a control
vector and infected the transfected cells with a murine cytomeg-
alovirus (MCMV) expressing luciferase under the control of the
HCMV immediate early promoter (MCMV-Luc). Luciferase
expression was measured 2 h after a synchronized infection to
quantify the activation of the immediate early promoter. The
results showed that only protein VI-wt was able to stimulate
immediate early promoter in the context of MCMV infection
(Figure 9C).
Taken together these results showed that protein VI promotes
immediate early gene expression from the adenoviral E1A
promoter, but it was also able to act on the immediate early gene
expression of a non-related virus.
In summary, our analysis provides an intriguing mechanistic
basis for cross genome activation of at least three unrelated DNA
viruses. Our data suggest that initiation of viral gene expression
can be achieved in cases where the respective virion proteins of
one virus are capable of removing Daxx dependent transcriptional
repression from the genome of the other virus.
Discussion
Here, we show that the capsid protein VI is necessary for
efficient initiation of Ad gene expression by activating the E1A
promoter and promoting initial expression of the E1A transacti-
vator, a function that had not been previously identified. E1A is a
crucial global transcriptional activator promoting early adenoviral
gene expression [37]. We show that E1A transcription and E1A
protein expression at the onset of viral gene expression are reduced
when cells are infected with an Ad mutant in which the PPxY
motif in the capsid protein VI is inactivated. E1A mRNA
production in this mutant increases with time and reaches
wildtype levels, suggesting that newly expressed E1A compensates
for the mutation in protein VI and drives adenoviral gene
expression as soon as critical concentrations have been reached
[37]. In addition, protein VI also stimulates other E1A dependent
Ad promoters in the absence of any viral protein suggesting that it
may act as a capsid derived E1A surrogate prior to the onset of
E1A expression. Thus, protein VI is an important regulator of
viral gene expression and links virus entry to the onset of gene
expression. This is at least in part mediated by counteracting
transcriptional repression imposed by the cellular Daxx protein
and can be substituted by functionally homologous capsid proteins
from unrelated DNA viruses.
In the nucleus, Daxx associates with chromatin and PML-NBs.
PML-NB association with Daxx is thought to alleviate gene
repression and activate apoptosis, while chromatin bound Daxx is
thought to act in a transcriptionally repressive manner [7,46,47].
A dynamic equilibrium of Daxx between PML-NBs and
chromatin association may thus govern the response status of
the host cell upon infection. Moreover, an antiviral interferon
response increases expression of PML and sensitizes cells for
apoptosis. Artificial knock down of PML increases replication of Ad
and other viruses, an observation that supports antiviral functions
of PML [reviewed in 4,21]. However, PML knock down also
decreases Daxx steady state levels by an unknown mechanism,
showing that antiviral activity might be mediated by Daxx rather
than PML [21]. This would be in line with our observation that
Daxx knock down has much stronger pro-replicative effects on Ads.
Here we demonstrate that Daxx directly represses Ad E1
promoters. So far, it has been shown that Daxx inactivates the
major immediate early promoter of HCMV [45], is recruited to
HSV genomes via SUMO dependent pathways [48] and is likely
to associate with incoming avian sarcoma virus (ASV) and human
immunodeficiency virus (HIV) genomes [49,50]. Therefore, Daxx
could act as a cytoplasmic and/or nuclear DNA sensor and may
be part of a cellular innate defence mechanism against DNA virus
infection (or other pathogens) by simply assembling repressive
complexes on incoming DNA [51]. This is supported by two
recent studies showing that Daxx selectively represses procaryotic
DNA expression [52] and that frequent epigenetic silencing of
integrated retroviral genomes could be reversed by Daxx
depletion, showing epigenetic control of pathogen DNA by Daxx
associated mechanisms [53]. Daxx mutants that fail to associate
with the HSV genome also fail to induce repression on the HSV
genome, underlining the important role of Daxx as part of the
cellular innate antiviral defence mechanism [48].
If Daxx serves in antiviral intrinsic immunity to repress viral
genomes, virion proteins are viral countermeasures. Several
structural proteins from viral particles have been reported to
interact with Daxx, including tegument protein pp71 [HCMV;
42,54], minor capsid protein L2 [HPV; 26], DENVC [Dengue
virus; 55], p6 [HIV GAG; 56], nucleocapsid protein PUUV-N
[Hantavirus; 57], Integrase [ASV, HIV; 49,53] and protein VI
(Ad, this study).
The best studied is the tegument protein pp71 of HCMV, which
enhances infectivity and replication through activation of the
immediate early promoter. This requires colocalization of the viral
genome with PML-NBs and Daxx degradation via pp71
[23,42,44,58,59]. In addition, pp71 was also shown to activate
gene expression from HSV-1, a different herpesvirus, showing that
its function is not restricted to HCMV [60]. Unlike for HCMV,
degradation of Daxx [through E1B-55K; 21] during Ad infection
requires early gene expression. Here we observe quantitative
removal of Daxx from PML-NBs upon infection without
degradation before gene expression is established. We propose
that this is caused by protein VI derived from the entering capsid,
which partially associates with PML-NBs during entry. Similar to
what we observe early in infection, transfected protein VI also
displaces Daxx from PML-NBs and translocates it into the
cytoplasm. Similarly, microinjected protein VI leads to rapid
exclusion of Daxx from PML-NBs and cytoplasmic accumulation
suggesting active removal following protein VI nuclear import.
Figure 5. Nedd4 binding to the PPxY prevents cytoplasmic translocation of Daxx by protein VI. Endogenous Daxx in U2OS cells was
detected following Mock transfection (A), transfection with VI-wt (B) or after cotransfection of VI-wt with Nedd 4.2 (C) or catalytical inactive Nedd 4.2-
TD (D), transfection of VI-M1 (E) or VI-M1 cotransfected with Nedd 4.2. (F) as indicated to the left of each row. Daxx was stained with Ab against the
endogenous protein (first column), VI was detected using the RFP signal (second column) or GFP for Nedd4 (third column). An overlay is shown in the
last column showing Daxx in blue, protein VI in red, Nedd4 in green and the nucleus in grey. Phenotypes shown in representative cells were observed
in all transfected cells. Colocalization of VI, Nedd4.2 and PML is shown in Figure S5.
doi:10.1371/journal.ppat.1002549.g005
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Figure 6. Daxx is displaced from PML bodies following Ad entry. (A) Endogenous Daxx (second column) and PML (third column) localization
was determined in U2OS (a–c) cells either in the absence of infection (a) or 1 h after a synchronous infection using 100 physical particles of Alexa647
labeled HH-Ad5-VI-wt (b) or HH-Ad5-VI-M1 (c) per cell (first column). In the overlay (last column) virus is depicted in white, Daxx in green and PML in
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Deletion of the N-terminal amphipathic helix from protein VI,
which serves as PML-NB targeting domain, still mediated the
transient dissociation of Daxx from PML-NBs suggesting that
competitive binding and a short residence time of Daxx in PML-
NBs can also cause Daxx removal from PML-NBs [43]. Daxx
depletion from PML-NBs also provokes intranuclear mobility and
clustering of PML, reminiscent of infected cells and showing that
Daxx contributes to the integrity of PML-NBs, which confirms
previous observations [10].
Ad-wt, but not a virus with the mutated PPxY-motif in protein
VI, counteracts Daxx repression for efficient viral gene expression.
Protein VI wt also induces a more rapid Daxx displacement from
PML-NBs and subsequent nuclear export than its mutated
counterpart. In contrast, binding of Nedd4-family ubiquitin ligases
to the PPxY of protein VI abolished cytoplasmic translocation of
Daxx at steady state, suggesting that Nedd4 binding to protein VI
competes with the interaction between Daxx and protein VI.
Increasing the efficiency of Daxx mobilization in the nucleus, and
simultaneously preventing Daxx nuclear export or limiting the
time Daxx resides in the cytoplasm through competitive binding to
Nedd4, could lead to efficient derepression and prevent Daxx from
activating apoptosis (via JNK pathways), which could explain why
Nedd4 binding is beneficial for the virus [10,61].
Displacing Daxx from PML-NBs immediately after virus entry
prevents antiviral apoptotic processes, possibly increasing Daxx
mediated repression by epigenetic silencing [reviewed in 5]. We
observe Daxx removal from PML-NBs for wt- as well as M1
mutated protein VI. In contrast, only wt-VI shows a strong
stimulation and direct association with viral E1 promoters as
determined by ChIP. In addition, proper transcriptional activation
of the E1A promoter required the presence of the amphipathic
helix. Thus, reversal of Daxx repression by protein VI from viral
promoters might provide an additional explanation for Nedd4
function and the role of the PPxY motif. Targeting Nedd4 to viral
promoters via the PPxY could result in ubiquitylation of histone or
the histone-like DNA bound viral protein VII or other Daxx
interactors, to open the chromatin structure for transcription.
In this scenario, protein VI would prevent formation or
disassemble already bound repressive complexes from viral
promoters via the PPxY motif and Nedd4. This would explain
why the M1 mutant still displaces Daxx from PML-NBs, but
retains only a minor capacity of stimulating viral gene expression
presumably through interfering with the assembly of new Daxx
repressive complexes. This model would also support the
observation that, like protein VI-M1, protein VI without
amphipathic helix (but intact PPxY and still capable of Daxx
binding) hardly stimulates the E1A promoter. This mutant is
diffusely distributed in the nucleus showing that the helix
contributes to proper intranuclear targeting of protein VI.
Mislocalization therefore could reduce the capacity to remove or
prevent assembly of Daxx repressive complexes on the E1A
promoter. How this mutant still retains some capacity of
stimulating E1A protein expression (and as a consequence partially
rescues the M1-virus) without activating the E1A promoter is
currently unclear.
Removal of Daxx by components of incoming virions to initiate
gene expression is a common viral strategy. Our experiments are
the first to show that the consequences are not virus-family
specific, but provoke global changes in transcriptional activity that
allow transcriptional activation of one viral genome (here the Ad
or MCMV genome) by the virion protein of unrelated viruses
(here pp71 from HCMV and L2 from HPV; or the CMV
promoter by protein VI). All three virion proteins (VI, pp71 and
L2) target Daxx repressive complexes. The details of these
interactions are not fully understood but they share similarities
as highlighted in the model in Figure 10. We suggest that
activation of viral gene expression for the three viral systems (Ad,
HCMV and HPV) involves prevention and removal of Daxx
repressive complexes. This is achieved by preventing Daxx-PML
interaction or association of Daxx repressive complexes with the
viral genome and (in some cases) involves the degradation of
components of the complex (Figure 10). Neither pp71 nor L2
contain a PPxY motif suggesting different modes of action on
Daxx or components of the Daxx repressive complex. Protein VI
is also not restricted to Ads in its de-repressive activity and is able
to stimulate the immediate early HCMV promoter. Several other
viral capsid proteins have been reported to encode PPxY motifs
[reviewed in 62]. The research focus for those motifs has been on
their role in virus budding despite the presence of these proteins in
the capsids of many viruses during virus entry. If virion derived
PPxY (and related motifs) are part of a more general activation
mechanism for several viruses then this could also mean that co-
infections with different viruses, frequently observed in vivo, could
promote each other. Similarly it is an interesting question, whether
superinfections of a latently infected cell by another de-repressive
virus would support reactivation of the latent genome. Epidemi-
ological data from a recent study show that Ad/HCMV co-
infections in vivo happen as often as mono-infections and the
authors suggest that this could reflect co-viral reactivation [63].
Our data would provide a mechanistic basis for this observation,
which is potentially applicable to several types of viral co-
infections.
Lastly, we believe that gene regulatory functions of viral
structural proteins should be considered when addressing safety
issues for the application of viral vectors (e.g. adenoviral vectors) in
therapeutic settings where (re)activation of unrelated (latent)
viruses is unwanted.
Materials and Methods
Cell culture
U2OS, H1299 and HepaRG cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum
(FCS), 100 U of penicillin, 100 mg of streptomycin per ml in a 5%
CO2 atmosphere at 37uC. For HepaRG and HAD (Daxx knock
down) cells media was supplemented with 5 mg/ml of bovine
insulin and 0.5 mM of hydrocortisone [20,21].
Transfections and luciferase reporter assays
Tagged protein VI, PML, Daxx and Nedd4 expression vectors
have been described previously [36,64]. E1A was expressed from
constructs encompassing the left part of the viral genome including
left inverted terminal repeat (ITR) and the E1 genes (pPG-S3). N-
terminal flag-tagged human PML-isoforms I-VI were expressed
from pLKO.1-puro vector (kindly provided by R. Everett). Codon
optimized HPV (type 16) L2 expression vector was kindly provided
red. Red arrows indicate PML without Daxx colocalization. Daxx-PML colocalizations following transfection of VI is shown in Figure S7. (B) PML-NBs
were counted in the nucleus at 1 h p.i. of non-infected cells (black bars) and cells infected as above with HHAd5-VI-wt (light grey bars) and HHAd5-VI-
M1 (dark grey bars) classed into groups as indicated on the x-axis. Over 60 cells were counted per condition. Significant difference between non-
infected vs. wt and non-infected vs. M1 infected cells was calculated using two-tailed 2-sample T-test (p,0.001).
doi:10.1371/journal.ppat.1002549.g006
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by M. Mueller, DKFZ Heidelberg. Expression vector pCGN71
[65] encodes an XbaI-BamHI PCR fragment 0corresponding to the
HCMV strain AD169 UL82. Dual luciferase assays were
performed according to manufacturers instructions and have been
described previously [66]. Promoter constructs are based on the
pGL3-basic vector (Invitrogen, cloning details will be provided
upon request).
Viruses
E1-deficient viral vectors BxAd5-VI-wt-GFP and BxAd5-VI-
M1-mCherry are based on human Ad serotype 5 and have been
cloned using homologous and site-specific recombination using
bacterial artificial chromosomes (BACs) as described in detail
recently [36]. Replication competent wt virus HH-Ad5-VI-wt is
identical to the previously described H5pg4100 [67]. The virus
mutant HH-Ad5-VI-M1 carries an altered PPxY motif in the
protein VI open reading frame [PPSY=.PGAA; Fig. S1; 36].
Viruses were constructed, propagated and titrated on HEK293
cells as detailed in Figure S1.
Indirect immunofluorescence and protein analysis
For immunofluorescence analysis cells were washed in PBS and
fixed for 20 min using 4% paraformaldehyde. Detection of
endogenous antigens using primary and secondary Ab was done
in IF-buffer (PBS with 10% FCS and 0.2% Saponin) followed by
washing and embedding in Prolong Gold (Invitrogen). A list of
primary and secondary Ab used in this study is given in Protocol
S1 in Text S1. Images are presented as maximum image
projections if not indicated otherwise. For protein analysis total-
cell lysates were prepared and analyzed by western blot using
standard protocols. The list of the antibodies used in this study and
details for immunoprecipitation (IP) procedures are given in
Protocol S1 and Protocol S2 in Text S1.
ChIP assay and quantitative real-time (qRT) PCR analysis
H1299 cells were infected with HH-Ad5-VI-wt or HH-Ad5-
VI-M1 at 50 fluorescence forming units/cell (FFU/cell) and
harvested 24 h p.i. ChIP analysis was performed as described
previously with some modifications [68,69]. For ChIP, proteins
from 26106 cells were cross-linked to DNA with 1% formalde-
hyde in PBS for 10 min at room temperature. The reaction was
quenched and cells were washed with PBS and harvested by
scraping off the dish. Nuclei were isolated by incubation of cross-
linked cells with 500 ml buffer I (50 mM Hepes-KOH, 140 mM
NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton
X-100) for 10 min on ice and pelleted by centrifugation. The
nuclei were subsequently washed with 500 ml buffer II (10 mM
Tris-HCl, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA),
pelleted again and resuspended in 500 ml buffer III (1% SDS,
10 mM EDTA, 50 mM Tris-HCl). Chromatin was fragmented
by sonication using a Bioruptor (Diagenode) to an average length
of 100–300 bp. After addition of 10% Triton X-100, cell debris
were pelleted by centrifugation (20,0006 g, 4uC) and superna-
tants were collected. Chromatin was diluted with dilution buffer
(0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM
Tris-HCl, 167 mM NaCl). To reduce non-specific background,
chromatin was pre-incubated with salmon-sperm DNA protein-A
agarose beads (Upstate). Antibodies were added and incubated
for 16 h at 4uC. Fifty ml agarose beads were added to precipitate
the chromatin-immunocomplexes for 4 h at 4uC. Beads were
washed once with low-salt buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris-HCl, 150 mM NaCl), once with
high-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris-HCl, 500 mM NaCl), once with LiCl-wash buffer
(0.25 M LiCl, 1% Nonidet P-40, 1% Na-deoxycholate, 1 mM
EDTA, 10 mM Tris-HCl) and twice with TE buffer. Chromatin
was eluted from the beads in elution-buffer (50 mM Tris-HCl
pH 8.0, 10 mM EDTA, 1% SDS) for 10 min at 95uC. Proteinase
K was added for protein degradation and samples were incubated
for 1 h at 55uC. For preparation of input controls, samples were
treated identical to IP samples except that non-specific Ab were
used. qPCR analysis was performed using a Rotor Gene 6000
(Corbett Life Sciences, Australia) in 0.5 ml reaction tubes
containing 1/100 dilution of the precipitated chromatin,
10 pmol/ml of each synthetic oligonucleotide primer (E1A fwd
59TCCGCGTTCCGGGTCAAAGT39; E1A rev59GTCGG-
AGCGGCTCGGAG39; E1B fwd 59GGTGAGATAATGTT-
TAACTTGC39 E1B rev 59TAACCAAGATTAGCC CAC-
GG39), 5 ml/sample SYBR Green PCR Master Mix (Applied
Biosystems). The PCR conditions used: 7 min at 95uC, 45 cycles
of 12 s at 95uC, 40 s at 60uC and 15 s at 72uC. The average Ct-
value was determined from triplicate reactions and normalized
against non-specififc IgG controls with standard curves for each
primer pair. The identities of the products obtained were
confirmed by melting curve analysis. For qPCR analysis, U2OS
cells were infected with 1, 10 and 200 physical particles/cell and
genome copy numbers were determined in nuclear and
cytoplasmic fractions using hexon specific primers [70].
Extraction and quantification of newly transcribed RNA
4sU (Sigma) was added to the cell culture media for 1 h, made
up to a final concentration of 200 mM, during indicated time
points throughout infection. Cells were harvested using Trizol
reagent (Invitrogen) and total RNA isolated by phenol-chloroform
extraction. Biotinylation and purification of 4sU-tagged RNA
(newly transcribed RNA), was performed as described previously
[71]. Five hundred ng of each newly transcribed RNA per reaction
was reverse transcribed in 25 ml reactions using Superscript III
(Invitrogen) and oligo-dT primers (Invitrogen) following the
manufacturer’s instructions. PCR was performed on a Light
Cycler (Roche Molecular Biochemicals). Each reaction, every
sample in duplicates, was carried out using 5 ml of cDNA (1:10
dilution) and 15 ml reaction mixtures of Quantitect SYBR Green
PCR master mix and 0.5 mM of the primers. PCRs were subjected
to 10 min of 95uC hot-start, and SYBR Green incorporation was
Figure 7. Microinjection of recombinant protein VI displaces Daxx from PML bodies and translocates it to the cytoplasm. (A) U2OS
cells were cotransfected with PML-GFP (left in each panel) and Daxx-mCherry expression plasmids (right in each panel). One cell of two neighboring
cells with similar expression levels was microinjected into the cytoplasm either with recombinant protein VI-wt (first row), recombinant protein VI-M1
(second row), recombinant protein delta54-VI (third row) or using a buffer control (fourth row). The left panel shows confocal images (midsection) of
the cells prior to injection, the right panel shows those after approx. 6–8 min after injection. Injected cells are indicated by arrows. Note the
cytoplasmic accumulation of Daxx (first and second rows). (B) The Coomassie stained gel shows the injected proteins used in A indicated by solid
arrows. Movies of injections shown in (A, first to third row) are provided as supplemental Videos S1, S2, S3. (C) Quantification of nuclear export of
Daxx following microinjection of recombinant protein VI-wt and VI-M1. Nuclear Daxx signal was monitored following cytoplasmic microinjection of
recombinant proteins and the loss of nuclear fluorescence was plotted. The initial timepoint of Daxx export from .15 cells per condition was
estimated and plotted as box-plots showing the median and average (red cross).
doi:10.1371/journal.ppat.1002549.g007
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Figure 9. HCMV tegument protein pp71 and HPV minor capsid protein L2 can substitute transcriptional activation of the Ad
genome. (A) H1299 cells were transfected with control vector, VI-wt, VI-M1 or VI-delta54 expression vector and subsequently infected with HH-Ad5-
VI-wt or HH-Ad5-VI-M1 at a MOI of 50 FFU/cell. Viral particles were harvested 24, 48 and 72 h p.i. and virus yield was determined using quantitative
E2A stain. (B) Experimental setup as in A including the use of the same empty vector control except that cells were transfected with expression vector
for the HCMV tegument protein pp71 or the HPV small capsid protein L2. Results are from three independent experiments. (C) U2OS cells were
transfected with control vectors or expression vectors for VI-wt or VI-M1 as indicated in the legend together with control expression vectors for
Renilla luciferase. Twenty four hours after transfection, cells were infected with MCMV encoding a firefly luciferase gene controlled by the HCMV
immediate early promoter. Two hours after infection cells were lysed and firefly luciferase levels were measured and normalized for renilla luciferase
expression by a dual luciferase assay. Expression levels were set to 100% for empty vectors. Results are the mean of two independent experiments
performed in six technical repeats. Error bars represent the STD.
doi:10.1371/journal.ppat.1002549.g009
Figure 8. HCMV tegument protein pp71 and HPV minor capsid protein L2 stimulate E1A promoter activation. (A) H1299 cells were
transfected with luciferase reporter plasmids coding for E1A promoter and effector plasmids encoding for VI-wt, VI-M1, VI-delta54, HCMV pp71, HPV
L2 or an empty vector as negative control. Forty eight hours after transfection, samples were lysed and luciferase activity was measured as described
before. Mean and standard deviation are from three independent experiments. (B) H1299 cells were co-transfected with plasmids containing the Ad5
E1-region (pPG-S3) and expression vector for VI-wt, VI-M1, VI-delta54, pp71 or L2. Total-cell extracts were prepared 48 h after transfection and
proteins were subjected to IB using Ab against RFP (pVI), pp71 or b-actin as indicated on the right. Note that several splice variants of E1A are
recognized depicted by the vertical bar. (C) Cells were transfected as in B and indicated in the legend to C. Forty eight hours after transfection total
RNA was prepared from cell lysates and reverse transcribed using oligo-dT primers. E1A mRNA levels were determined using qPCR with E1A specific,
exon-spanning primers. Values correspond to the mean of two experiments done in triplicates and the error bar indicates the STD.
doi:10.1371/journal.ppat.1002549.g008
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monitored for 45 cycles of 95uC denaturation for 10 s, 58uC
annealing for 3 s, and 72uC elongation for 10 s. The data were
analyzed using the DDCt method using GAPDH as an
endogenous reference, and the mock-infected sample as a
calibrator. Values were normalized to 100% for wt-infected cells.
The E1A 13S mRNA specific and the GAPDH specific primers
were described in [72]. Primers used are listed below: E1A13S-fwd
(59-GGC TCA GGT TCA GAC ACA GGA CTG TAG),
E1A13S-rev (59-TCC GGA GCC GCC TCA CCT TTC),
GAPDH-fwd (59-TGG TAT CGT GGA AGG ACT CA),
GAPDH-rev (59-CCA GTA GAG GCA GGG ATG AT).
Microinjection and protein purification
Details for microinjection are given in the Figure 8 and video
legends (Video S1). Briefly, U2OS cells were cotransfected with
PML-GFP and Daxx-mCherry expression plasmids and cultivated
on a heated stage (37uC) in CO2 stabilized medium attached to a
SP5 confocal microscope (Leica) equipped with a microinjection
device (Eppendorf). Microinjected cells were imaged within a
single confocal plane at the nuclear midsection at 20 s intervals for
10 frames prior to injection and 40 frames post injection. Injected
proteins were purified as His-tagged proteins using standard
procedures and dialyzed into transport buffer as detailed
previously [30,36].
Statistical analysis
Data are presented as mean, error bars as standard deviation
(STD). Statistical analysis was done using paired students t-test
except for Figure 6B where a two-tailed two sample t-test was
used. The p-values are indicated.
List of accession numbers for proteins used in this study
Human Daxx CAG33366.1, Protein VI AAA96411.1, Human
Adenovirus Type 5 HY339865, PML-I AAG50180, PML-II
AF230410, PML-III S50913, PML-IV AAG50185, PML-V
AAG50181, PML-VI AAG50184, HCMV pp71 ACZ79993.1,
humanized HPV L2 (HPV16).
Supporting Information
Figure S1 Construction of virus mutant HH-Ad5-VI-M1
by site directed mutagenesis. (A) For the construction of the
replication competent virus mutant HH-Ad5-VI-M1, the Ad5 wild
type genome in HH-Ad5-VI-wt [H5pg4100; 67] was inserted into
the PacI site of the bacterial cloning vector pPG-S2 [67]. It lacks
nucleotides (nt) 28593 to 30471 (encompassing most of E3) and
contains an additional unique endonuclease restriction site at nt
30955 (BstBI) (nucleotide numbering is according to the published
Ad5 sequence from GenBank, accession no. AY339865). In vitro
mutagenesis was used to introduce the M1 mutation into the
transfer vector pL3 containing the protein VI gene. The resulting
transfer vector pL3-M1 was used to replace the SgfI-PmeI fragment
in the genome encoding plasmid to generate HH-Ad5-VI-M1. For
generation of the HH-Ad5-VI-M1 and the wt control virus,
infectious viral DNA was released from the recombinant plasmids
by PacI digestion and transfected into the complementing cell line
2E2 [73]. Viral progeny was amplified in 2E2 cells followed by
purification on CsCl2 gradients. The integrity of the recombinant
virus was verified by restriction digest and DNA sequencing of the
entire protein VI gene from isolated viral DNA. (B) For subsequent
infection experiments, virus stocks were titered on HEK293 cells
[74] and fluorescent forming units were determined by E2A stain
for viral replication centers. Virus growth was determined by
harvest of infected cells at 24, 48 and 72 h p.i. followed by three
freeze/thaw cycles. The cell lysates were serially diluted and virus
yield was determined by quantitative E2A stain, 24 h after
infection of HEK293 cells as described previously [75]. Viral
supernatants were normalized for infectious units (e.g. 50
fluorescence forming units, FFU) prior to use in experiments
showing roughly four fold higher ratio of infectious to non
infectious particles for the HH-Ad5-VI-wt compared to HH-Ad5-
VI-M1.
(TIF)
Figure S2 Quantification of viral genomes in fraction-
ated cells. (A) U2OS cells were synchronously infected with
replication competent HH-Ad5-wt or HH-Ad5-M1 virus at 200,
10 or 1 physical particles per cell (pp/cell) as virus input –A-. Forty
five min after infection, the cytoplasmic –B- and nuclear –C-
fractions were separated using nucleo-cytoplasmic fractionation
according to the manufacturer’s protocol (Pierce). Each fraction
was subjected to extraction of the adenoviral genomes using the
high pure viral nucleic extraction kit (Roche) according to the
manufacturer’s instructions. The viral genomes were quantified in
–A-, -B- and –C- by qPCR using AQ1 and AQ2 oligonlucleotides
to amplify part of the hexon gene [described in 70]. Serial dilutions
of a pcDNA3.1 plasmid coding for the Ad5 hexon were used to
obtain the standard curve for quantification. The copy number of
viral genomes of each fraction was calculated from the Ct-values
obtained for each sample. Values were used to determine the cell-
associated viral genomes and expressed as percentage of virus
input (1 = 1006(B+C/A) reflecting cell binding and virus entry
capacity. The percentage of nuclear-associated genomes was
calculated and expressed as percentage of total cell-associated
genomes (2 = 1006(C/B+C) This value represents viral genomes
associated with the nuclear fraction after transport towards the
nucleus. To identify how many genomes initiate replication, cells
were infected in parallel and stained for replication centers at 24 h
p.i. using E2A specific Ab. E2A positive cells were counted and the
Figure 10. Model for genome activation of DNA viruses through structural proteins of the virion. A schematic representation of Daxx
restriction mediated by human adenovirus capsid protein VI (A), HCMV tegument protein pp71 (B) and HPV minor capsid protein L2 (C). Daxx
repressive complexes (containing the two transcriptional repressor Daxx and ATRX) assemble at PML-NBs and/or on viral genomes. Transcriptional
activation of the viral genome requires removal of Daxx repressive complexes and/or the prevention of their assembly possibly involving PML-NBs.
(A) The adenoviral E1A promoter is activated through targeting of Daxx by the adenoviral capsid protein VI and presumably Nedd4 ligases. This
requires an N-terminal amphipathic helix and a conserved PPxY motif on protein VI. The latter is required for binding and nuclear targeting of Nedd4
ligases. As a consequence Daxx is not degraded but likely is displaced from the viral genome and PML-NBs thereby removing and preventing
assembly of new Daxx repressive complexes on the viral genome. The fate of the removed complexes including ATRX is currently not clear. (B) For
HCMV the major immediate early promoter (MIEP) is activated through tegument protein pp71, which binds to Daxx and mediates its proteasomal
degradation thus removing ATRX and preventing Daxx repressive complexes on the viral genome. (C) The major HPV promoter is repressed by Daxx
related mechanisms although very little is currently known. Daxx is targeted by the minor capsid protein L2, which also modulates PML-NBs.
However, a formal role in Daxx de-repression of the viral promoter or a role for ATRX has not been established. Nevertheless, we show in this report
the cross-activation of the adenoviral E1A promoter by pp71 and L2 and the activation of the MIEP by protein VI suggesting a common principle of
genome activation.
doi:10.1371/journal.ppat.1002549.g010
Adenoviral Genome Activation
PLoS Pathogens | www.plospathogens.org 19 February 2012 | Volume 8 | Issue 2 | e1002549
percentage of E2A positive cells was calculated –D-. In order to
discriminate between a viral expression defect and a decrease in
virus nuclear transport and accumulation that could account for a
loss of expression, the percentage of E2A positive cells was
normalized with the percentage of nuclear-associated genome
(3 =D/2). To quantify the M1 defects, both the cell-and nuclear-
associated genomes of the mutant and the E2A expression were
compared to the wt values and presented as percentage of wt.
(B) Quantification of intracellular viral genomes and genome
replication as in A. Cell-associated genomes are the sum of nuclear
and cytoplasmic fractions normalized for total viral input while
nuclear-associated genomes were normalized to cell-associated
genomes. Twenty four hours p.i., the expression of the E2A
marking viral replication was quantified in parallel infected cells
and the percentage of E2A positive cells was normalized for
nuclear-associated genomes. All data for M1 are expressed as
percentage of the HH-Ad5-pVI-wt virus ( = 100%). * mean value
(+/2 STD) from independent experiments at 200, 10 and 1 pp/
cell (each done in triplicates). Note that differences are MOI
independent except for E2A expression. Reduction of M1 virus in
the cell associated fractions was likely due to post-endosomolytic
degradation because previous work showed equal efficiency for
both viruses in membrane lysis [36]. The additional reduction of
the M1 virus in the nucleus-associated fraction was independent of
the pp/cell ratio and reflects nuclear accumulation defects, as
observed for the M1 non-replicative virus in our previous study
[36]. The reduced initiation of replication for the M1 virus at low,
but not high MOIs, explains why production yields and virus
amplification of the M1 mutant virus is unaffected at high pp/cell
ratios while up to 20-fold reduced infection rates can be observed
at low pp/cell ratios [Fig. 1; 36].
(TIF)
Figure S3 PML-NB association of protein VI requires
the amphipathic helix. To identify the domain of protein VI
required for PML-NB association, several mRFP tagged constructs
for protein VI were transfected into U2OS cells and stained for
association with endogenous PML. The mRFP signal is shown in
the left column. An overlay of the mRFP protein VI signal (red),
endogenous PML (green) and the nuclear envelope stained with
MAb 414 (Abcam) against the nuclear pore complex (grey) is
shown in the right column. Association of protein VI and PML is
depicted by a white arrow and magnified in the top right corner as
inset to each overlay panel. Transfected constructs with the
functional domains amphipathic helix, nuclear localization signal
(NLS) and PPxY motif and their respective modification are
indicated to the left. Top to bottom : full length wt protein VI as
used in the transfections in Figure 2B (a), C-terminal processed wt
protein VI (b), as b with mutated PPxY motif (c), processed protein
VI with deleted amphipathic helix (delta 54, d), processed protein
VI with two essential tryptophan residues mutated [W37/41; 31]
in the amphipathic helix (e) and the same construct as full length
version (f). This analysis confirmed that protein VI is targeted to
PML-NBs and localized in close proximity to PML. Association of
protein VI with PML-NBs was not affected when the PPxY motif
was mutated (c) or when processed protein VI, as it is present in
the entering virus, was used (b). However, mutating or deleting the
amphipathic helix of protein VI changes its distribution from a
dot-like pattern towards a partial or complete diffuse, predominant
nuclear localization and with loss of its PML-NBs association (d, e,
f). These data indicate that the amphipathic helix was a major
determinant in targeting protein VI towards PML-NBs. Note that
clustering of endogenous PML-NBs in the transfected cells still
occurs when the amphipathic helix is mutated or deleted.
(TIF)
Figure S4 Protein VI mediates adenovirus transcrip-
tional activation of all Ad promoters. Subconfluent H1299
cells were transfected with luciferase reporter plasmids encoding
for the E1A-, E1B-, pIX-, E2early-, E2late-, E3-, E4-promoters
and the major late promoter (MLP) and effector plasmids
expressing VI-wt, VI-M1. Fortyeight hours after transfection,
samples were lysed and absolute luciferase activity was measured
as described by the manufacturer (dual luciferase kit/Promega). The
luciferase activity of each individual promoter was normalized to
100%. The means are presented for three independent experi-
ments. Error bars represent STD. The results show that protein VI
stimulates all adenoviral promoters between ,1.5 to ,4 fold
independent of any other adenoviral protein. Most stimulation is
achieved by protein VI-wt compared to protein VI-M1. This is an
indication that Daxx repressive mechanisms largely control
adenoviral gene expression and that protein VI is an important
transactivator that requires the PPxY motif to be fully active.
(TIF)
Figure S5 Protein VI targets Nedd4 ligases to PML-NBs
via the PPxY motif. U2OS cells were transfected with expression
constructs for GFP-tagged Nedd4 ligases and RFP-tagged expression
constructs for protein VI-wt or VI-M1 and stained for endogenous
PML, as indicted to the left of each row. From top to bottom;
Nedd4.1-GFP was cotransfected with VI-wt (a) or VI-M1 (b), Nedd4.2
was cotransfected with VI-wt (c) or VI-M1 (d) or VI-wt was
cotransfected with a catalytical inactive mutant of Nedd4.2 (TD, e).
An overlay of endogenous PML (grey, first column), Nedd4 (green,
second column) and VI (red, third column) is shown in the fourth
column. The small inset in each panel shows a magnification of the
grey box in the overlay, highlighting colocalization of the three
proteins at PML-NBs. Please note that only VI-wt, but not VI-M1,
targets Nedd4 ubiquitin ligases to PML-NBs irrespective of the ligase
activity. This analysis shows that Nedd4 ligases can be efficiently
imported into the nucleus and targeted to PML-NBs, by binding to the
PPxY motif of protein VI. We were unable to show that during Ad
entry Nedd4 is also translocated into the nucleus or towards PML-NBs
due to the bad quality of existing Nedd4 Ab. The observation that
transfected protein VI can translocate transfected Nedd4 into the
nucleus raises the possibility that incoming particles could also relocate
Nedd4 ligases towards the nucleus through association with capsid
associated protein VI and alter physiological functions and/or exploit
Nedd4 family members to initiate and promote viral replication.
(TIF)
Figure S6 Transfected viral capsid proteins partially
displace Daxx from PML bodies.H1299 (a–c) and U2OS (d–
f) cells were transfected with either empty control plasmid (a, d) or
mRFP-tagged VI-wt (b, e) or mRFP-tagged VI-M1 (c) or with an
HA-tagged expression vector for the pp71 tegument protein of the
human cytomegalovirus (f, all first columns). Transfected cells
were stained for endogenous Daxx (second column) and
endogenous PML (third column). The localization of capsid
proteins was determined using the RFP signal for VI-wt and VI-
M1 or using Ab against the HA-tag to detect pp71 tegument
protein. An overlay of all three signals is shown in the last column
were capsid proteins are shown in white, Daxx in green and PML
in red. Note that red arrows point at PML without (b, c) or with
reduced (d) Daxx colocalization or at pp71 induced nuclear
structures recruiting Daxx and PML (f). This analysis shows that
protein VI (wt and M1) alone is capable of displacing Daxx from
PML-NBs and support that protein VI is responsible for the
observations made in Figure 6, which show that adenovirus
infection results in displacement of Daxx from PML-NBs prior to
gene expression. Using different cell lines further supports that
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protein VI mediated displacement of Daxx from PML-NBs is a
genuin property of protein VI. We observed that PML-NB
displacement and cytoplasmic accumulation of Daxx was most
efficient in H1299 cells while in U2OS cells Daxx was less
prominently associated with PML-NBs at steady-state and also
less prominently translocated to the cytoplasm upon VI-wt
expression. In contrast, expression of VI-M1 let to very efficient
Daxx translocation and cytoplasmic colocalization in all three cell
lines tested. The observed clustering of PML following transfec-
tion is reminiscent of the induced mobility and fusion observed
for transfected PML after Daxx displacement in cells microin-
jected with protein VI as it is shown in Figure 7 and Videos S1
and S2.
(TIF)
Figure S7 Protein VI-wt activates the CMV promoter of
E1-deleted Ad vector particles with M1 mutated protein
VI. U2OS cells were transduced with 1 physical particle per cell
(pp/cell) of E1-deleted viral vector BxAd5-VI-M1-mCherry
(expressing mCherry under CMV promoter control and M1
mutated protein VI) and different amounts of viral vector BxAd5-
VI-wt-GFP (expressing GFP under CMV promoter control and wt
protein VI). The ratios of M1- to wt-virus are indicated on the x-
axes (values in pp/cell). Transduction levels were determined by
FACS and are shown separately for M1 (mCherry, light grey bars)
and wt (GFP, dark grey bars). The dotted lines indicate wt
transduction levels at 1 pp/cell or M1 transduction levels at 1 pp/
cell as indicated to the right of the graphic. The increased
transduction levels with the M1-virus co-incided with co-
transduction of wt-vectors (data not shown). The data show that
expression of (CMV-promoter-driven) mCherry from the genome
of the E1-deleted Ad vector that encodes protein VI with the M1
mutation is restored when the same cell is also transduced with wt-
vector particles that contain protein VI-wt. This observation
supports a role for protein VI in activating the CMV promoter
and shows that an adenoviral protein (capsid protein VI) can
activate the early promoter of a non-related DNA virus
(immediate early promoter of HCMV). Because Daxx represses
the CMV promoter [45], transactivation by protein VI presum-
ably occurs through removal of Daxx repression.
(TIF)
Text S1 The supporting information contains a list of all
antibodies used in this study (Protocol S1), a detailed
protocol for the co-immunoprecipitation assays (Protocol
S2) and additional references used in Figures S1, S2, S3,
S4, S5, S6, S7.
(DOC)
Video S1 Microinjection of recombinant protein VI-wt
displaces Daxx from PML bodies to the cytoplasm. U2OS
cells were cotransfected with Daxx-mCherry (left panel) and PML-
GFP (middle panel) expression plasmids (superimposed signal on the
right) and cultivated at 37uC on a heated stage in CO2 stabilized
medium attached to a SP5 confocal microscope equipped with a
microinjection device (Eppendorf). The left cell of two cotransfected
cells with equal expression levels of both proteins was then
microinjected into the cytoplasm using recombinant protein VI at
a final concentration of 0.3 mg/ml. Prior to injection, cells were
imaged using the SP5 confocal microscope at 20 s intervals for 10
frames at a single optical section with pinhole setting of two using a
206 magnification and maximum resolution. Injection was
performed manually under optical control in DIC mode and
immediately after images were taken at 20 s intervals for further 40
frames without changing the optical setting to minimize the time
between injection and imaging (time delay ,1–2 min). Note the
cytoplasmic accumulation of the Daxx signal following injection.
(AVI)
Video S2 Microinjection of recombinant protein VI-M1
displaces Daxx from PML bodies to the cytoplasm.
U2OS cells were cotransfected with Daxx-mCherry (left panel) and
PML-GFP (middle panel) expression plasmids (superimposed signal
on the right) and cultivated at 37uC on a heated stage in CO2
stabilized medium attached to a SP5 confocal microscope equipped
with a microinjection device (Eppendorf). The left cell of two
cotransfected cells with similar expression levels of both proteins was
then microinjected into the cytoplasm using recombinant bacterially
expressed and purified protein VI-M1 at a final concentration of
0.3 mg/ml. Prior to injection, cells were imaged using the SP5
confocal microscope at 20 s intervals for 10 frames at a single optical
section with pinhole setting of two using a 206magnification and
maximum resolution. Injection was performed manually under
optical control in DIC mode and immediately after images were
taken at 20 s intervals for further 40 frames without changing the
optical setting to minimize the time between injection and imaging
(time delay ,1–2 min). Please note the increase of PML
intranuclear dynamics in the injected cell that starts as soon as the
Daxx signal diminishes. This dynamic was seen in all cells injected
with VI-wt or with VI-M1 but never in buffer injected control cells.
(AVI)
Video S3 Microinjection of recombinant protein VI-
delta54 transiently displaces Daxx from PML bodies but
fails to export Daxx to the cytoplasm. U2OS cells were
cotransfected with Daxx-mCherry (left panel) and PML-GFP
(middle panel) expression plasmids (superimposed signal on the
right) and cultivated at 37uC on a heated stage in CO2 stabilized
medium attached to a SP5 confocal microscope equipped with a
microinjection device (Eppendorf). The left cell of two cotransfected
cells with similar expression levels of both proteins was then
microinjected into the cytoplasm using recombinant bacterially
expressed and purified protein VI-delta54 at a final concentration of
0.3 mg/ml. Prior to injection, cells were imaged using the SP5
confocal microscope at 20 s intervals for 10 frames at a single optical
section with pinhole setting of two using a 206magnification and
maximum resolution. Injection was performed manually under
optical control in DIC mode and immediately after images were
taken at 20 s intervals for further 40 frames without changing the
optical setting to minimize the time between injection and imaging
(time delay ,1–2 min). Please note that Daxx temporarily is
displaced from PML-NBs (,0–3 min post-injection) followed by a
return to PML-NBs. During Daxx displacement please also note the
increase of PML intranuclear dynamics in the injected cell that
diminishes with the return of Daxx to the PML-NBs.
(AVI)
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